Hyperacusis survey results 13 july 2014

Benefit Risk from a Healthcare Provider Perspectiive

MS Coalition DMT Consensus 2014

Ken smith slides 5th uclp ms research day

Future efficacy measures for Multiple Sclerosis

Switching therapy: SINS Santiago 2014

Natalizum safety and pml risk stratification july 2014

MS frontiers 2013 brochure

Chugai sa237 inclusion and exclusion criteria

Giovannoni ectrims 2014 presentation endorse neda draft 3 sept 04

Imperial College MS Study Day 2014

Natalizumab vs. Alemtuzumab

Bull ms lottery of care 2013

Ms related abstracts ens june 2013 barcelona

Thrombotic microangiopathy and nephrotic syndrome risk on if nbeta mhra sept 2014

Treatment Highlights ECTRIMS 2012

Disease-activity free status talk - Cleveland Clinic 20 Sept 2012

Early effective treatments

eHealth presentation at ENS-EFN Istanbul

Ebv & Multiple Sclerosis